At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MRNA Moderna, Inc.
Not Yet Opened 12-04 16:00:00 EST
25.49
+0.31
+1.23%
盘后25.50
+0.01+0.04%
19:57 EST
High25.90Low24.70Vol8.53M
Open25.20D1 Closing25.18Amplitude4.75%
Mkt Cap9.96BTradable Cap9.26BTotal Shares390.68M
T/O216.85MT/O Rate2.35%Tradable Shares363.29M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Moderna Inc. Stock Rallies 4.7%, Outperforms Peers
Dow Jones  ·  12-04 05:35
Moderna Inc. Stock Rallies 4.7%, Outperforms Peers
Reasons To Be Optimistic About The S&P 500's Worst-Performing Stocks
Dow Jones  ·  12-03 13:20
Reasons To Be Optimistic About The S&P 500's Worst-Performing Stocks
Moderna Exec Says Co Hasn't Seen the Data or Analysis Behind FDA Claims Linking Covid Vaccines to Children's Death - Conf Call
THOMSON REUTERS  ·  12-03 00:34
Moderna Exec Says Co Hasn't Seen the Data or Analysis Behind FDA Claims Linking Covid Vaccines to Children's Death - Conf Call
TRADING DAY-World shivers on Japan rate chill
Reuters  ·  12-02
TRADING DAY-World shivers on Japan rate chill
Moderna Inc. Stock Slips 7.0%, Underperforms Peers
Dow Jones  ·  12-02
Moderna Inc. Stock Slips 7.0%, Underperforms Peers
UK Gains Zero-Tariff Access for Medicines Under New US Trade Pact
MT Newswires Live  ·  12-02
UK Gains Zero-Tariff Access for Medicines Under New US Trade Pact
Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men
Dow Jones  ·  12-02
Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men
BUZZ-U.S. STOCKS ON THE MOVE-Ideaya Biosciences, Omnicom Group, Targa Resources
Reuters  ·  12-02
BUZZ-U.S. STOCKS ON THE MOVE-Ideaya Biosciences, Omnicom Group, Targa Resources
Vaccine Stocks Falls as FDA Vows to Impose New Vaccine Requirements
Tiger Newspress  ·  12-01
Vaccine Stocks Falls as FDA Vows to Impose New Vaccine Requirements
Stock Track | Moderna Stock Plunges 5% as FDA Memo Links Child Deaths to COVID Vaccines
Stock Track  ·  12-01
Stock Track | Moderna Stock Plunges 5% as FDA Memo Links Child Deaths to COVID Vaccines
Stock Track | Moderna Stock Plummets 5% Intraday After FDA Memo Links COVID Vaccines to Child Deaths
Stock Track  ·  12-01
Stock Track | Moderna Stock Plummets 5% Intraday After FDA Memo Links COVID Vaccines to Child Deaths
Stock Track | Moderna Stock Plummets 5% Intraday After FDA Memo Links COVID Vaccines to Child Deaths
Stock Track  ·  12-01
Stock Track | Moderna Stock Plummets 5% Intraday After FDA Memo Links COVID Vaccines to Child Deaths
BUZZ-U.S. STOCKS ON THE MOVE-Coupang, Zscaler, gold miners
Reuters  ·  12-01
BUZZ-U.S. STOCKS ON THE MOVE-Coupang, Zscaler, gold miners
Shares of Some U.S. Vaccine Makers Fall Premarket After FDA Memo Links Child Deaths to Covid Shots
THOMSON REUTERS  ·  12-01
Shares of Some U.S. Vaccine Makers Fall Premarket After FDA Memo Links Child Deaths to Covid Shots
Moderna Down 3.4%, Novavax Down 1.4%
THOMSON REUTERS  ·  12-01
Moderna Down 3.4%, Novavax Down 1.4%
BUZZ-Vaccine makers fall after US FDA memo links child deaths to COVID shots
Reuters  ·  12-01
BUZZ-Vaccine makers fall after US FDA memo links child deaths to COVID shots
FDA's Prasad Cites Alleged Child COVID Shot Deaths in Push for Stricter Rules
Benzinga_recent_news  ·  11-30
FDA's Prasad Cites Alleged Child COVID Shot Deaths in Push for Stricter Rules
Moderna Inc. Stock Climbs 3.9%, Outperforms Peers
Dow Jones  ·  11-29
Moderna Inc. Stock Climbs 3.9%, Outperforms Peers
The AI Pharma Rally Is Real — And Cancer May Soon Be Chronic, Not Deadly
Benzinga_recent_news  ·  11-27
The AI Pharma Rally Is Real — And Cancer May Soon Be Chronic, Not Deadly
Berenberg Trims Price Target on Moderna to $26 From $28, Keeps Hold Rating
MT Newswires Live  ·  11-26
Berenberg Trims Price Target on Moderna to $26 From $28, Keeps Hold Rating

Introduction

Company Name.
Moderna, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Issue price:
--